https://pubmed.ncbi.nlm.nih.gov/21562037/?dopt=Abstract
EGFR signaling regulates tumor cell migration in craniopharyngiomas
Our data suggest EGFR signaling to play a role in cell migration and brain infiltration of adaCP. Targeting the EGFR signaling pathway by gefitinib may present...
cell migrationegfrsignalingtumorcraniopharyngiomas
https://ascopost.com/news/july-2023/vemurafenib-plus-cobimetinib-in-newly-diagnosed-patients-with-papillary-craniopharyngiomas/
Vemurafenib Plus Cobimetinib in Newly Diagnosed Patients With Papillary Craniopharyngiomas - The...
In a small phase II trial reported in The New England Journal of Medicine, Priscilla K. Brastianos, MD, and colleagues found that the BRAF-MEK inhibitor...
newly diagnosedplus